Back to Journals » Drug Design, Development and Therapy » Volume 16

Drug Design, Development and Therapy


Archive: Volume 16, 2022

Feasibility of Catalpol Intranasal Administration and Its Protective Effect on Acute Cerebral Ischemia in Rats via Anti-Oxidative and Anti-Apoptotic Mechanisms

Wang J, Zhang Y, Zhang M, Sun S, Zhong Y, Han L, Xu Y, Wan D, Zhang J, Zhu H

Drug Design, Development and Therapy 2022, 16:279-296

Published Date: 25 January 2022

Inhibition of JNK Phosphorylation by Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury [Corrigendum]

Xiao Z, Xu F, Zhu X, Bai B, Guo L, Liang G, Shan X, Zhang Y, Zhao Y, Zhang B

Drug Design, Development and Therapy 2022, 16:249-250

Published Date: 19 January 2022

Advances in Engineered Three-Dimensional (3D) Body Articulation Unit Models

Chen Y, Wang Y, Luo SC, Zheng X, Kankala RK, Wang SB, Chen AZ

Drug Design, Development and Therapy 2022, 16:213-235

Published Date: 18 January 2022

Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A Syndrome

Lee CL, Chuang CK, Chiu HC, Tu RY, Lo YT, Chang YH, Lin SP, Lin HY

Drug Design, Development and Therapy 2022, 16:143-154

Published Date: 10 January 2022

Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway

Li H, Luo K, Yang Z, Chen M, Yang X, Wang J, Ying Y, Wu D, Wang Q

Drug Design, Development and Therapy 2022, 16:129-141

Published Date: 11 January 2022

Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis

Chanprapaph K, Pomsoong C, Kositkuljorn C, Suchonwanit P

Drug Design, Development and Therapy 2022, 16:107-116

Published Date: 7 January 2022

Inhibition of CXCR4 in Spinal Cord and DRG with AMD3100 Attenuates Colon-Bladder Cross-Organ Sensitization

Zhang H, Dong X, Yang Z, Zhao J, Lu Q, Zhu J, Li L, Yi S, Xu J

Drug Design, Development and Therapy 2022, 16:67-81

Published Date: 6 January 2022

Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action

Mohd Zaid NA, Sekar M, Bonam SR, Gan SH, Lum PT, Begum MY, Mat Rani NNI, Vaijanathappa J, Wu YS, Subramaniyan V, Fuloria NK, Fuloria S

Drug Design, Development and Therapy 2022, 16:23-66

Published Date: 6 January 2022

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum]

Liu Y, Zhang N, Zhang H, Wang L, Duan Y, Wang X, Chen T, Liang Y, Li Y, Song X, Li C, Han D, Chen B, Zhao W, Yang Q

Drug Design, Development and Therapy 2022, 16:1-2

Published Date: 5 January 2022